Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psilocybin-assisted therapy for depression: A systematic review and meta-analysis
Sipan Haikazian, David Chen‐Li, Danica E. Johnson, et al.
Psychiatry Research (2023) Vol. 329, pp. 115531-115531
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin
Joshua D. Rosenblat, Shakila Meshkat, Zoe Doyle, et al.
Med (2024) Vol. 5, Iss. 3, pp. 190-200.e5
Closed Access | Times Cited: 32
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 2
Emerging Medications for Treatment-Resistant Depression: A Review with Perspective on Mechanisms and Challenges
Michael J. Lucido, Boadie W. Dunlop
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 161-161
Open Access | Times Cited: 2
The Role of Mitochondrial Dysfunction and Calcium Dysregulation in 2C-I and 25I-NBOMe-Induced Neurotoxicity
Eva Gil-Martins, Fernando Cagide, A. Borer, et al.
Chemico-Biological Interactions (2025), pp. 111425-111425
Closed Access | Times Cited: 2
Giving Consent to the Ineffable
Daniel Villiger
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 11
Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression
Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, et al.
Psychoactives (2024) Vol. 3, Iss. 2, pp. 215-234
Open Access | Times Cited: 10
Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review
Noah Chisamore, Danica E. Johnson, Margery J.Q. Chen, et al.
Journal of Psychiatric Research (2024) Vol. 176, pp. 77-84
Closed Access | Times Cited: 6
Personal psychedelic experience of psychedelic therapists during training: should it be required, optional, or prohibited?
Daniel Villiger
International Review of Psychiatry (2024), pp. 1-10
Open Access | Times Cited: 6
Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials
Shuping Fang, Xin Yang, Wei Zhang
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 5
The Future of Enhanced Psychotherapy: Towards Precision Psychotherapy
Stephan Zipfel, Wolfgang Lutz, Silvia Schneider, et al.
Psychotherapy and Psychosomatics (2024) Vol. 93, Iss. 4, pp. 230-236
Closed Access | Times Cited: 4
A New Trick of Old Dogs: Can Kappa Opioid Receptor Antagonist Properties of Antidepressants Assist in Treating Treatment-Resistant Depression (TRD)?
Shaul Schreiber, Lee Keidan, Chaim G. Pick
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 208-208
Open Access
History of psychedelic drug science and molecular pharmacology
David E. Nichols, Charles D. Nichols
International review of neurobiology (2025)
Closed Access
Vermont Primary Care Provider Perspectives on Psychedelics — A Cross-Sectional Study
Josephine Yalovitser, jonah levine, Cole Zweber, et al.
Journal of Psychoactive Drugs (2025), pp. 1-7
Closed Access
The Effects of Psychedelic-Assisted Therapy on Illness and Death Anxiety: A Systematic Review and Meta-Analysis
Aron Amaev, Jianmeng Song, Yasaman Kambari, et al.
Journal of Psychiatric Research (2025)
Closed Access
Pharmacological Monotherapy for Depressive Disorders: Current and Future, a Narrative Review
Keming Gao, Evrim Bayrak Oruc, Buket Koparal
Medicina (2025) Vol. 61, Iss. 4, pp. 558-558
Open Access
Pharmacokinetics of Psilocybin: A Systematic Review
Shakila Meshkat, Huda Al-Shamali, Argyrios Perivolaris, et al.
Pharmaceutics (2025) Vol. 17, Iss. 4, pp. 411-411
Open Access
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l’étude
Noah Chisamore, Erica Kaczmarek, Zoe Doyle, et al.
The Canadian Journal of Psychiatry (2025)
Closed Access
Exploring psilocybin’s role in mental health and palliative medicine: a path to improved well-being
Maria-Alejandra Umbacia, Marta León, Jose-Manuel Quintero, et al.
Expert Opinion on Emerging Drugs (2025)
Closed Access
De Novo Biosynthesis of Antidepressant Psilocybin in Escherichia coli
Zhangrao Huang, Yongpeng Yao, Rong Di, et al.
Microbial Biotechnology (2025) Vol. 18, Iss. 4
Open Access
Anhedonia as a Core Symptom of Depression and a Construct for Biological Research
Majd Al‐Soleiti, Jennifer L. Vande Voort, Balwinder Singh
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 2, pp. 163-172
Closed Access
Psychedelics for Depression: Between Hopes and Uncertainties
Trisha Suppes, Mathieu Fradet
FOCUS The Journal of Lifelong Learning in Psychiatry (2025) Vol. 23, Iss. 2, pp. 206-207
Closed Access
Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs
Nicholas C. Borgogna, Tyler Owen, Dan Petrovitch, et al.
Psychopharmacology (2025)
Open Access
Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile Analysis
Jérémie Richard, Jeremy Scott, Sandeep M. Nayak, et al.
International Journal of Mental Health and Addiction (2025)
Closed Access
Therapeutic Effects of Low-Dose Psilocybin in Depression and Other Mental Disorders: A Systematic Review
Shakila Meshkat, Howell Fang, Venkat Bhat, et al.
Psychedelic Medicine (2025)
Closed Access
Neurobiology of the Antidepressant Effects of Serotonergic Psychedelics: A Narrative Review
Noah Chisamore, Erica Kaczmarek, Gia Han Le, et al.
Current Treatment Options in Psychiatry (2024) Vol. 11, Iss. 2, pp. 90-105
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top